• Today
    July 09

  • 01:42 AM

Drug Service statement on Diabetes medication


Added 06 June 2020


The Barbados Drug Service (BDS) has advised diabetic patients who use the pharmaceutical drug, metformin, that they should continue to do so and discuss any concerns with their physicians.

In a statement today, the BDS said that it had been drawn to its attention that some patients had either stopped or were concerned about taking long acting metformin following statements in the overseas media about the drug by the United States Food and Drug Administration (US FDA).

The medication is prescribed for the treatment of Type 2 diabetes.

According to the BDS, as a result of a press release issued by the FDA, the pharmaceutical corporation, Apotex, voluntarily withdrew its brand of metformin from the market but the BDS made it clear that this brand was not available in Barbados.

The statement cautioned: “The current situation does not warrant patients ceasing to take this medication. Patients who have been prescribed metformin are advised to discuss their concerns with their physician, should they need further reassurance about taking the drug.” (BGIS)


Dos and Donts

Welcome to our discussion forum here on nationnews.com. We encourage lively debate, but we also urge you to take note of the following:

  • Stay on topic – This helps keep the thread focused on the discussion at hand. If you would like to discuss another topic, look for a relevant article.
  • Be respectful – Meeting differences of opinion with civil discussion encourages multiple perspectives and a positive commenting environment.
  • Do not type in capitals – In addition to being considered “shouting” it is also difficult to read.
  • All comments will be moderated – Given the volume of comments each day, this may take some time. So please be patient.
  • We reserve the right to remove comments – Comments that we find to be abusive, spam, libellous, hateful, off-topic or harassing may be removed.
  • Reproduction of comments – Some of your comments may be reproduced on the website or in our daily newspapers. We will use the handle, not your email address.
  • Do not advertise – Please contact our Advertising Department.
  • Contact our Online Editor if you have questions or concerns.
  • Read our full Commenting Policy and Terms of Use.
comments powered by Disqus


Should the headquarters of a new regional airline remain in Antigua & Barbuda?